Abstract:
본 발명은 패각을 이용한 액상 칼슘 시트레이트(C12H14CaO14) 또는 모노 칼슘 시트레이트 분말의 제조방법 및 이의 응용에 관한 것으로, 더욱 상세하게는 패각 분말과 구연산을 이용하여 액상 칼슘 시트레이트를 제조하고, 이를 건조시켜 모노 칼슘 시트레이트를 제조하는 방법 및 이의 응용에 관한 것이다.
Abstract:
The present disclosure relates to methods for the production of the isomerically pure or isomerically enriched cis-clomiphene and salts thereof.
Abstract:
A composition for treating headaches and migraines and methods of using same for preventative use to decrease the frequency, duration and severity of headaches and migraines in children and adults.
Abstract:
The present invention provides a cocrystal of (S)-3-(1-((1-acryloylpyrrolidin-3-yl)oxy)isoquinolin-3-yl)-1H-1,2,4-triazol-5(4H)-one and an organic acid capable of forming a cocrystal with the compound. Specific cocrystals prepared are cocrystals with gentisic acid, salicylic acid, maleic acid, malonic acid, malic acid, mandelic acid and citric acid.
Abstract:
The invention relates to various compositions for improving exercise performance and/or recovery. The invention also relates to methods of using these compositions and kits including these compositions to improve exercise performance and/or recovery.
Abstract:
The invention provides a method for preparing a succinic acid, which method comprises the steps of - providing magnesium succinate; - acidifying the magnesium succinate with hydrochloric acid (HC1), thereby obtaining a solution comprising succinic acid and magnesium chloride (M g C1 2 ); - optionally a concentration step, wherein the solution comprising succinic acid and M g C1 2 is concentrated; - precipitating succinic acid from the solution comprising succinic acid and M g C1 2 , thereby obtaining a succinic acid precipitate and a M g C1 2 solution. The inventors found that the addition of HC1 to a magnesium salt of succinic acid and subsequent precipitation of succinic acid from the solution leads to a very efficient separation of succinic acid from a magnesium succinate solution.
Abstract:
The present invention relates to novel solid forms of agomelatine (I), specifically novel pharmaceutically acceptable cocrystals thereof, as well as to methods of preparing them. Three pharmaceutically acceptable cocrystals of (I) that have physicochemical properties acceptable for pharmaceutical development were obtained.